In vitro activity of amiloride combined with tobramycin against Pseudomonas isolates from patients with cystic fibrosis.
The diuretic amiloride has been under recent investigation as adjunctive therapy for pulmonary disease in children with cystic fibrosis (CF). In preliminary studies, the antimicrobial activity of this agent alone or combined with beta-lactam agents against reference strains of Pseudomonas aeruginosa...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1988
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172183/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3364958/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.3.395 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|